Area of research
Oncology · Molecular Biology
Research interest
Research interests include Gut microbiota and health, Clostridium difficile and Clostridium perfringens research, Neutropenia and Cancer Infections, and COVID-19 and healthcare impacts.
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease
Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremia
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation
A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients
Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species
Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients
Customization of a DADA2-based pipeline for fungal internal transcribed spacer 1 (ITS1) amplicon data sets
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Determinants of COVID-19 disease severity in patients with cancer
The gut microbiota is associated with immune cell dynamics in humans
High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Lactose drives <i>Enterococcus</i> expansion to promote graft-versus-host disease
Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus
Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition
Antibiotic-Induced Shifts in Fecal Microbiota Density and Composition during Hematopoietic Stem Cell Transplantation
Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant
Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
Impact of gut colonization with butyrate producing microbiota on respiratory viral infection following allo-HCT
Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer